Aurinia Pharmaceuticals Inc (AUPH)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -51.444 | -57.358 | -38.2 | -52.416 | -25.984 | -35.941 | -21.333 | -15.314 |
Return on Equity (%) | -83.326 | -70.198 | -46.077 | -64.154 | -30.144 | -40.811 | -24.461 | -19.919 |
Return on Invested Capital (%) | -82.224 | -45.846 | -39.574 | -43.581 | -31.644 | -41.974 | -26.449 | -25.422 |
Operating Margin (%) | -13465.318 | -16855.238 | -13833.045 | -38887.736 | -205.064 | -395.145 | -79.349 | -42.558 |
Net Profit Margin (%) | -13465.318 | -16855.238 | -13848.812 | -38945.283 | -204.876 | -396.812 | -80.713 | -44.453 |
Book Value Per Share | 0.386 | 1.804 | 1.169 | 2.346 | 3.144 | 3.324 | 2.805 | 2.593 |
Earnings Per Share | -0.441 | -0.842 | -0.75 | -1.108 | -0.81 | -1.278 | -0.76 | -0.542 |
Cash Per Share | 0.751 | 1.971 | 1.38 | 2.737 | 2.149 | 1.638 | 0.662 | 0.34 |
Working Capital Per Share | 0.634 | 1.988 | 1.469 | 2.718 | 3.057 | 3.338 | 2.787 | 2.417 |
Operating Profit Per Share | 0.003 | 0.005 | 0.005 | 0.003 | 0.395 | 0.314 | 0.913 | 1.126 |
EBIT Per Share | -0.441 | -0.842 | -0.749 | -1.106 | -0.811 | -1.273 | -0.748 | -0.539 |
EBITDA Per Share | -0.441 | -0.842 | -0.749 | -1.106 | -0.811 | -1.273 | -0.748 | -0.539 |
Free Cash Flow Per Share | -0.469 | -0.859 | -0.767 | -1.121 | -0.776 | -1.291 | -0.763 | -0.542 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 5.223 | 21.503 | 18.296 | 27.901 | 13.108 | 12.629 | 9.598 | 5.503 |
Quick Ratio | 5.011 | 21.297 | 17.363 | 27.126 | 12.464 | 11.846 | 8.738 | 4.853 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | 101.428 | 154.676 | 67.406 | 82.571 |
Shares Outstanding | 52.81M | 84.05M | 85.5M | 111.8M | 126.73M | 141.6M | 142.27M | 143.83M |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 141.89M | 142.11M | 142.27M | 143.03M | 143.37M | 143.61M | 143.83M | 143.69M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -74.893 | N/A | N/A | N/A | -17.349 |
Net Profit Margin (%) | N/A | N/A | N/A | -76.16 | N/A | N/A | N/A | -21.369 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 10.076 | N/A | N/A | N/A | 5.605 |
Quick Ratio | N/A | N/A | N/A | 9.052 | N/A | N/A | N/A | 4.909 |
Inventory Turnover (Days) | N/A | N/A | N/A | 336.741 | N/A | N/A | N/A | 288.507 |
Market Cap | 776.6M |
Price to Earnings Ratio | -9.99 |
Price to Sales Ratio | 4.44 |
Price to Cash Ratio | 15.95 |
Price to Book Ratio | 2.06 |
Dividend Yield | - |
Shares Outstanding | 143.02M |
Average Volume (1 week) | 1.48M |
Average Volume (1 Month) | 1.24M |
52 Week Change | -50.73% |
52 Week High | 12.43 |
52 Week Low | 4.71 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.